Comparison of adrenergic agonists for the treatment of ventricular fibrillation and pulseless electrical activity
dc.contributor.author | Bleske, Barry E. | en_US |
dc.contributor.author | Billi, John E. | en_US |
dc.date.accessioned | 2006-04-10T17:43:00Z | |
dc.date.available | 2006-04-10T17:43:00Z | |
dc.date.issued | 1994-12 | en_US |
dc.identifier.citation | Bleske, Barry E., Billi, John E. (1994/12)."Comparison of adrenergic agonists for the treatment of ventricular fibrillation and pulseless electrical activity." Resuscitation 28(3): 239-251. <http://hdl.handle.net/2027.42/31146> | en_US |
dc.identifier.uri | http://www.sciencedirect.com/science/article/B6T19-4C06CV1-8/2/881e289175884dffefa065cf832f90dd | en_US |
dc.identifier.uri | https://hdl.handle.net/2027.42/31146 | |
dc.identifier.uri | http://www.ncbi.nlm.nih.gov/sites/entrez?cmd=retrieve&db=pubmed&list_uids=7740195&dopt=citation | en_US |
dc.description.abstract | The primary role of epinephrine for the treatment of ventricular fibrillation (VF) and pulseless electrical activity (PEA) is to increase blood flow to the myocardium and central nervous system and ultimately improve survival. However, despite the administration of epinephrine, survival following VF or PEA is low. In an attempt to improve outcome from VF and PEA, alternative adrenergic agonists (methoxamine, phenylephrine, norepinephrine) which have different pharmacological properties than epinephrine have been evaluated. In order to determine the role of alternative adrenergic agonists for the treatment of VF and PEA this paper will compare the pharmacological properties and pharmacodynamic effects of these drugs to epinephrine. Specifically, receptor physiology along with the effects of adrenergic agonists on coronary perfusion pressure, survival, myocardial oxygen demand, and cerebral blood flow will be discussed. | en_US |
dc.format.extent | 1430746 bytes | |
dc.format.extent | 3118 bytes | |
dc.format.mimetype | application/pdf | |
dc.format.mimetype | text/plain | |
dc.language.iso | en_US | |
dc.publisher | Elsevier | en_US |
dc.title | Comparison of adrenergic agonists for the treatment of ventricular fibrillation and pulseless electrical activity | en_US |
dc.type | Article | en_US |
dc.rights.robots | IndexNoFollow | en_US |
dc.subject.hlbsecondlevel | Family Medicine and Primary Care | en_US |
dc.subject.hlbtoplevel | Health Sciences | en_US |
dc.description.peerreviewed | Peer Reviewed | en_US |
dc.contributor.affiliationum | College of Pharmacy, University of Michigan, Ann Arbor, MI 48109-1065, USA | en_US |
dc.contributor.affiliationum | College of Pharmacy, University of Michigan, Ann Arbor, MI 48109-1065, USA | en_US |
dc.identifier.pmid | 7740195 | en_US |
dc.description.bitstreamurl | http://deepblue.lib.umich.edu/bitstream/2027.42/31146/1/0000043.pdf | en_US |
dc.identifier.doi | http://dx.doi.org/10.1016/0300-9572(94)90070-1 | en_US |
dc.identifier.source | Resuscitation | en_US |
dc.owningcollname | Interdisciplinary and Peer-Reviewed |
Files in this item
Remediation of Harmful Language
The University of Michigan Library aims to describe library materials in a way that respects the people and communities who create, use, and are represented in our collections. Report harmful or offensive language in catalog records, finding aids, or elsewhere in our collections anonymously through our metadata feedback form. More information at Remediation of Harmful Language.
Accessibility
If you are unable to use this file in its current format, please select the Contact Us link and we can modify it to make it more accessible to you.